infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 46 articles from: Treatment outcomes

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • The VA Will Eliminate Hepatitis C In Veterans By Year-end

    Forbes / 02 March 2018

  • Ethnic disparities evaporate with DAA treatment of hepatitis C infections

    ModernMedicine / 06 February 2018

  • Low skeletal muscle mass improves after successful HCV treatment

    Healio Hepatology / 22 November 2017

  • Fatty Liver Common After Direct-Acting Antivirals for Hep C

    Medscape (requires free registration) / 01 November 2017

  • Direct-acting antivirals successfully treating hepatitis C, says Public Health England

    Pharmaceutical Journal / 02 August 2017

  • Hep C Experts Condemn Cochrane Review Dissing Direct Antivirals

    MedPage Today / 28 June 2017

  • Response to the Cochrane Systematic Review on DAA-Based Treatment of Chronic Hepatitis C

    EASL / 28 June 2017

  • AASLD Expresses Concern for Cochrane Review of DAAs

    AASLD / 26 June 2017

  • Australian Health Organisations refute Cochrane Review Report and affirm efficacy of Direct Acting Antiviral (DAA) therapy for hepatitis C

    Manual Items / 26 June 2017

  • Cochrane condemned for 'bizarre' review of new hep C drugs

    Australian Doctor / 19 June 2017

← Prev12345Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//